Marie Stiborová
Researcher Next ID · RN-041957
Researcher · Biochemistry, Genetics and Molecular Biology
Prague, Czechia
- Works count
- 468
- Citation count
- 14,009
- H-index
- 60
- i10-index
- 259
Research interests
Publications
DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer
International Journal of Molecular Sciences · 2017 · 10.3390/ijms18102144
Histone Deacetylase Inhibitors as Anticancer Drugs
International Journal of Molecular Sciences · 2017 · https://doi.org/10.3390/ijms18071414
Balkan endemic nephropathy: an update on its aetiology
Archives of Toxicology · 2016 · 10.1007/s00204-016-1819-3
The Role of Metallothionein in Oxidative Stress
International Journal of Molecular Sciences · 2013 · https://doi.org/10.3390/ijms14036044
Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
International Journal of Oncology · 2013 · https://doi.org/10.3892/ijo.2013.2223
Sarcosine as a Potential Prostate Cancer Biomarker—A Review
International Journal of Molecular Sciences · 2013 · https://doi.org/10.3390/ijms140713893
Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy
International Journal of Cancer · 2013 · 10.1002/ijc.28681
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy
Annals of Internal Medicine · 2013 · 10.7326/0003-4819-158-6-201303190-00006
Mammalian metallothioneins: properties and functions
Metallomics · 2012 · https://doi.org/10.1039/c2mt20081c
Metallothioneins and zinc in cancer diagnosis and therapy
Drug Metabolism Reviews · 2012 · https://doi.org/10.3109/03602532.2012.725414
Modern Micro and Nanoparticle-Based Imaging Techniques
Sensors · 2012 · https://doi.org/10.3390/s121114792
Ellipticine cytotoxicity to cancer cell lines - a comparative study
Interdisciplinary Toxicology · 2011 · https://doi.org/10.2478/v10102-011-0017-7
Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances
Pharmacology & Therapeutics · 2011 · https://doi.org/10.1016/j.pharmthera.2011.07.006
Vertebrate metallothioneins as target molecules for analytical techniques
TrAC Trends in Analytical Chemistry · 2010 · https://doi.org/10.1016/j.trac.2010.02.004
Mutagenicity and DNA adduct formation of PAH, nitro-PAH, and oxy-PAH fractions of atmospheric particulate matter from São Paulo, Brazil
Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2008 · 10.1016/j.mrgentox.2007.12.007
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice
Carcinogenesis · 2007 · 10.1093/carcin/bgn002
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy
Mutation Research/Reviews in Mutation Research · 2007 · 10.1016/j.mrrev.2007.07.003
Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
Carcinogenesis · 2007 · 10.1093/carcin/bgm082
Evaluation of Isoflavone Aglycon and Glycoside Distribution in Soy Plants and Soybeans by Fast Column High-Performance Liquid Chromatography Coupled with a Diode-Array Detector
Journal of Agricultural and Food Chemistry · 2005 · https://doi.org/10.1021/jf0502754
Environmental Pollutant and Potent Mutagen 3-Nitrobenzanthrone Forms DNA Adducts after Reduction by NAD(P)H:Quinone Oxidoreductase and Conjugation by Acetyltransferases and Sulfotransferases in Human Hepatic Cytosols
Cancer Research · 2005 · 10.1158/0008-5472.can-04-3544
Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid‐DNA adducts found in patients with urothelial cancer
International Journal of Cancer · 2004 · 10.1002/ijc.20564
The Anticancer Drug Ellipticine Forms Covalent DNA Adducts, Mediated by Human Cytochromes P450, through Metabolism to 13-Hydroxyellipticine and EllipticineN2-Oxide
Cancer Research · 2004 · 10.1158/0008-5472.can-04-2202
Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers
Cancer Letters · 2004 · 10.1016/j.canlet.2004.07.036
Sanguinarine and chelerythrine: assessment of safety on pigs in ninety days feeding experiment
Food and Chemical Toxicology · 2003 · 10.1016/j.fct.2003.08.007
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
Carcinogenesis · 2003 · 10.1093/carcin/bgg119
Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
PubMed · 2002
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
Chemico-Biological Interactions · 2002 · https://doi.org/10.1016/s0009-2797(01)00285-x
Human Enzymes Involved in the Metabolic Activation of Carcinogenic Aristolochic Acids: Evidence for Reductive Activation by Cytochromes P450 1A1 and 1A2
Chemical Research in Toxicology · 2001 · 10.1021/tx010059z
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts☆
Biochemical Pharmacology · 2001 · 10.1016/s0006-2952(01)00806-1
Effect of heavy metal ions on growth and biochemical characteristics of photosynthesis of barley and maize seedlings
Biologia Plantarum · 1987 · 10.1007/bf02882221
Current projects
No projects listed.